By Priscila Mayumi Kashiwabara
13 de September de 2023
New subject codes for filing applications for GMP certification for biological products industries
Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good Manufacturing Practices certifications – GMP (“BPF” in Portuguese) for biological products industries.
Formerly, the protocol was carried out under subject codes related to Medicines – Sterile Products. In such scenario, the Brazilian FDA faced difficulties in monitoring the processes, and the procedures were more complex.
According to the Agency, the applicant is not required to make any changes to the petitions that have already been filed, as they will be regularly analyzed by the responsible department.
Find below the list of new subjects that must be used for new requests:

For more news and content related to ANVISA, please do not hesitate to contact us at: regulatorio@kasznarleonardos.com.
Last by Priscila Mayumi Kashiwabara
25 de August de 2026
Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
On August 25, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of a Collaborative Patent Application Examination Project in … Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents